Tier-2 city expansion: what the digital footprint tells you first
Tier-2 city expansion decisions usually rest on population and bed ratios, which describe supply, not behaviour. A new city’s digital footprint shows what people search for, which hospitals they trust or criticise, which specialties they travel out for and whether your brand is already known. Treat it as a first filter that sharpens the site visit, not a replacement for it.
Before anyone flies in to walk a land parcel or tour a hospital that might be acquired, a growth team can learn a surprising amount about a new city from a laptop. Where people search for care, which hospitals they review and what they complain about, which specialties send patients out of the city, which doctors have a real following, how insurers have built their networks. All of it sits in public or in your own data, waiting to be read.
Tier-2 city expansion decisions in Indian healthcare are usually driven by real estate, promoter relationships and a feasibility study built on population and bed ratios. Those inputs matter. But they describe supply and demographics, not behaviour. The digital footprint describes behaviour: what people in that city actually do when they need care, and where the current providers are letting them down.
I treat this desk work as the first filter, not the final word. It will not tell you whether to build. It will tell you which questions to ask on the ground, which specialties to test and which assumptions in the feasibility report deserve a second look.
What a feasibility report misses in tier-2 city expansion
A typical feasibility report for a new city looks at population, income bands, existing bed capacity, a few competitor profiles and a projected occupancy curve. It is built from secondary data and interviews. It is necessary, and it is incomplete.
What it usually misses is the texture of demand. Two cities with similar populations and bed counts can behave completely differently. In one, most complex care already stays local because a couple of trusted hospitals have built strong specialty teams. In the other, families routinely travel to the nearest metro for anything serious, because they do not trust local options. The second city is a much bigger opportunity for a new entrant with credible specialists, and the first is a much harder fight. Population data cannot tell them apart. Search behaviour, review patterns and your own patient data often can.
The feasibility report also tends to treat competitors as bed counts. The digital footprint shows them as brands: which ones people trust, which ones they praise for doctors but criticise for billing, which ones barely exist online. That is far more useful when you are deciding how to position an entry.
Start with your own data: who already travels to you
The most underused source is the one you already own. If your group runs hospitals in a nearby metro, some patients from the target city are almost certainly already coming to you. The question is whether your systems can see them.
Pull registrations and enquiries by home district or city for the last couple of years. Look at which specialties they come for, how they found you, which doctors referred them and how their journeys ended. If the data is thin because nobody captured home city consistently, that tells you something about your own readiness as well.
This view answers two questions no external study can. It shows which specialties already draw patients out of the target city, which is a direct signal of unmet local demand. And it shows whether your brand already has a presence there, carried home by families who were treated well. A new hospital that can open with a base of past patients and referring doctors who know the name starts from a very different place than one arriving cold.
Look at the referring doctors in particular. If a handful of physicians in the target city already send patients to your metro hospital, they are the most valuable relationships you have there. They know your doctors, they have seen how their patients were treated, and they will have views on what a local hospital would need to offer. Their opinion is worth more than any survey.
Search demand: reading intent, not just volume
Search data for the target city tells you what people are looking for and, with some care, how they are looking for it. Raw volume matters less than pattern. Are people searching for specialties by name, or only for “hospital near me”? Are they searching for doctors by name? Are metro hospital brands appearing in local searches, which suggests people are already looking outward? How much searching happens in the regional language?
I look for gaps between what people search for and what local providers offer online. If there is steady search interest for a specialty and the local results are thin, outdated or dominated by listings from hospitals in another city, that is a signal. It does not prove the specialty will work locally, but it tells you where demand is poorly served.
AI assistants add a newer layer. Ask them the questions a family in that city might ask about local care and see which hospitals and doctors they name, and how confidently. The AI search visibility audit gives a structured way to do this for a set of specialties. If the answers keep pointing people to the metro, the city’s own providers have left the field open.
Pay attention to language. In many tier-2 cities, a large part of health searching happens in the regional language, or in a mix of scripts, and the content that answers those searches is thin. A new entrant that plans proper regional-language content from the start can own a space the incumbents have ignored, and that advantage compounds over time as the content earns trust and links.
Maps and reviews: the competitors as patients see them
Local search listings and reviews are the most honest competitor research available. Read them in bulk, not just the star ratings. What do people praise? What do they complain about? Is the anger about doctors, nursing, billing, waiting, cleanliness or the emergency department? How do the hospitals respond, if they respond at all?
Patterns in reviews tell you where the incumbents are vulnerable and what a new entrant would need to get right from the first day. If every hospital in the city is criticised for billing surprises, transparent pricing becomes a positioning opportunity. If complaints cluster around the emergency department, that tells you where the city’s trust is weakest, and also where a new hospital’s reputation will be made or lost fastest.
Look at listing quality too. Hospitals with incomplete, unclaimed or inaccurate listings are often weaker operators in other ways. A city where the major providers manage their local presence carefully is a more competitive market than one where nobody bothers.
Doctors online: who has a following
In most tier-2 cities, a small number of doctors carry enormous local trust. They often have their own clinics, strong word of mouth, and a visible online presence through reviews, videos or local media. Identifying these doctors early matters for two reasons.
First, they shape where patients go. If the most trusted cardiologist in the city is closely tied to one hospital, that hospital’s cardiac programme is hard to challenge without an equally credible name. Second, some of them may be potential partners, consultants or hires. Recruitment decisions in a new city are growth decisions, and the digital footprint helps you see who patients already follow before you start conversations.
Be careful with this information. It is for understanding the market, not for building dossiers on individuals. Stick to what doctors have made public in a professional capacity, and let the medical leadership lead any conversations.
The payer map and the specialty mix
Insurance and scheme networks are public enough to map. Which hospitals are empanelled with the major insurers and TPAs, which accept government scheme patients, which corporate employers in the city have tie-ups where. This shapes demand as much as any marketing, because in many tier-2 cities a large share of hospital admissions runs through some form of scheme or insurance.
Put the payer map next to the search, review and patient data, and a specialty picture starts to emerge. You can see which specialties have demand, weak local supply and a payer base that will fund them. That becomes the starting point for the specialty mix conversation, which I have argued should happen with the demand data on the table rather than on instinct.
Watch for specialties where the payer map and the demand signals disagree. Strong search interest for a service that local insurers rarely cover, or that schemes reimburse at rates a private hospital cannot sustain, can look like an opportunity and turn out to be a trap. The finance team needs to see those cases flagged early, before they turn into assumptions in the model.
The same method works when the question is an acquisition rather than a new build. The approach in reading an acquisition target through its digital footprint is essentially this analysis narrowed to one hospital.
What the footprint cannot tell you
Digital signals are strong on behaviour and weak on several things that matter a great deal. They cannot tell you the quality of local clinical talent beyond reputation. They cannot tell you how hard it will be to recruit and keep nurses. They say little about land, approvals, promoter dynamics or the local political environment. They underrepresent older, poorer and less connected patients, who may search less but still need care.
They can also mislead. A burst of reviews can be manufactured. Search interest can reflect curiosity rather than intent. A doctor with a big social following may have a small practice. Every signal needs to be tested on the ground, through conversations with local doctors, chemists, diagnostic centres, insurers and patients.
That is why I frame the digital work as a way to sharpen the site visit, not replace it. Going in with a clear list of hypotheses (this specialty is underserved, this incumbent is weak on billing, these districts send patients to the metro) makes the ground research far more productive.
Turning the findings into an entry plan
If the decision is to go ahead, the same work becomes the foundation of the launch plan. The specialties with the clearest demand gaps become the lead propositions. The review patterns tell you which service promises to make and keep. The list of trusted local doctors informs recruitment and referral outreach. The search and AI assistant findings tell you what content and local presence need to exist well before opening.
Much of what worked in your home city will not transfer as neatly as people hope. I wrote about this in opening in a new city. Brand awareness, doctor reputations and referral relationships are local, and they have to be rebuilt. The digital footprint helps you see how much rebuilding is needed and where to start.
The findings also belong in the investment case. When a board is asked to approve capital for a new city, a clear view of demand behaviour, competitor weakness and the group’s existing presence makes a much stronger argument than population ratios alone. That is the same logic behind making the digital case for capex.
Six weeks of desk work before the first site visit
If a new city is on the table, I would give the growth and digital team about six weeks before anyone travels, with a clear set of outputs:
- A view of patients who already travel from the target city to the group’s hospitals, by specialty, source and referring doctor.
- A search and AI assistant review of the main specialties, including regional-language behaviour and where searches currently lead.
- A review analysis of the leading local hospitals, summarising strengths, complaints and how they manage their local presence.
- A list of doctors with strong public followings in the specialties under consideration.
- A payer map covering the major insurers, TPAs, government schemes and corporate tie-ups.
- A short set of hypotheses for the site visit to confirm or reject.
None of this requires expensive tools or outside consultants. It requires someone who knows how to read behaviour in data and is willing to present uncomfortable findings, such as a favoured specialty showing little local demand. That discipline, applied before the first visit, saves a lot of money and a lot of arguments later.
Questions people ask
Tier-2 city expansion is when a hospital group moves into a smaller Indian city beyond the major metros, through a new build, an acquisition or a management arrangement. From a growth perspective, it means understanding how people in that city search for and choose care, which providers they trust, which specialties send patients elsewhere and how the local payer network works, before committing capital.
Behaviour. A feasibility study describes population, income and bed capacity. The digital footprint shows what people actually do when they need care: what they search for, which hospitals they praise or criticise, which specialties they travel out for and whether your brand already has a presence. That changes which specialties you lead with and how you position the entry.
Evidence that demand for the proposed specialties is real and poorly served, a clear view of the payer mix that will fund it, and a sense of how strong the incumbents are. The digital analysis also helps test the ramp-up assumptions in the feasibility model. If patients already travel from the city to your existing hospitals, the early volume assumptions rest on firmer ground.
A focused team can produce a useful picture in around six weeks. That covers internal patient data, search and AI assistant review, competitor reviews, doctor presence, the payer map and a set of hypotheses for the site visit. It does not replace ground research. It makes the ground research sharper and helps leadership avoid anchoring on assumptions that the data does not support.
Because it shows real behaviour that no external study can. Patients from the target city who already travel to your hospitals reveal which specialties are underserved locally and whether your brand is known there. If your systems do not capture home city consistently, fixing that is worth doing anyway. It improves every future expansion decision, not just the current one.
Where their patients are happy and where they are angry. Reading reviews in bulk shows patterns around doctors, nursing, billing, waiting times and emergency care. Those patterns show where the incumbents are vulnerable and what a new entrant must get right from the first day. How hospitals respond to reviews, if at all, also says a lot about their management discipline.
From the start, especially on doctor mapping and specialty choices. The digital analysis can show which doctors patients trust and which specialties look underserved, but only clinical leadership can judge talent, programme feasibility and what a credible service would need. Any conversations with local doctors should be led by the medical side, with growth providing the market context.
Yes, if it stays within their public professional presence and serves market understanding. Look at what doctors have made public about their practice, their reviews and their visibility. Avoid building personal dossiers or collecting private information. Treat the findings with discretion and let medical leadership handle any direct approach, since these are also potential colleagues.
It underrepresents patients who search less, often older, poorer or less connected people who still need care. Reviews can be manipulated, search interest can reflect curiosity rather than intent, and online following does not always match practice size. It also says nothing about land, approvals, staffing or local politics. Every signal needs testing on the ground.
The same findings become the launch plan. Specialties with clear demand gaps lead the proposition, review patterns tell you which service promises to make, the doctor list informs recruitment and referral outreach, and search findings define the content and local presence that must exist before opening. Doing this early saves months of scrambling in the pre-launch period.
Yes. The same method, narrowed to one hospital, shows how patients see the target: its reviews, search presence, doctor reputations, payer relationships and brand strength relative to local competitors. It often surfaces issues or strengths that financial due diligence misses, such as a billing reputation problem or a department whose local following is stronger than its numbers suggest.
A view of which doctors and specialties carry local trust, which informs recruitment priorities, and early signals about the local talent market from job listings and professional networks. HR should also use it to plan the employer brand in the new city, since nurses and staff choose employers partly on reputation, just as patients choose hospitals.
Whether demand for the lead specialties is proven by behaviour, not just demographics. Whether patients from the city already come to the group. How strong and trusted the incumbents are. What the payer mix looks like. Which assumptions were tested on the ground. Those questions show whether the case rests on evidence or on enthusiasm for a particular site.
Usually not. Most of the work uses your own patient data, public search and review information, and structured questioning of AI assistants. What it needs is an analyst who can read behaviour in data and a leader willing to present findings honestly, including ones that challenge a preferred site or specialty. Consultants can help on the ground, where local access matters more.
